Impact of adherence to a Mediterranean Diet pattern on patients with first acute myocardial infarction

Marco Magnoni1, Paola Scarano1, Vittoria Vergani1

  • 1IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.

Abstract

Insights

Adherence to the Mediterranean diet (MD) positively impacts C-reactive protein levels and myocardial reperfusion in ST-elevation Myocardial Infarction (STEMI) patients. This highlights MD

Area of Science:

  • Cardiology
  • Nutrition Science
  • Preventive Medicine

Background:

  • The Mediterranean diet (MD) is known to influence myocardial infarction risk and long-term outcomes.
  • Limited data exist on the MD's impact on short-term prognosis following acute coronary events.
  • This study investigates MD adherence in patients experiencing their first ST-elevation Myocardial Infarction (STEMI).

Purpose of the Study:

  • To assess the effect of Mediterranean diet adherence on in-hospital and short-term outcomes.
  • To evaluate the relationship between MD adherence and inflammatory markers post-STEMI.
  • To determine if MD influences myocardial reperfusion after treatment.

Main Methods:

  • 533 European STEMI patients without prior coronary disease were analyzed.
  • The FAMI Mediterranean Diet Score (FAMI MD Score) assessed dietary habits via a food frequency questionnaire.
  • High-sensitivity C-Reactive Protein (hsCRP) and Interleukin-6 (IL-6) levels were measured within 6 hours of symptom onset.

Main Results:

  • Higher FAMI MD Score correlated with lower hsCRP levels; IL-6 showed no significant differences.
  • No association was found between MD adherence and 180-day adverse events.
  • Lower MD adherence was linked to a higher risk of ineffective myocardial reperfusion.

Conclusions:

  • The Mediterranean diet and fruit/vegetable intake show a positive effect on hsCRP and myocardial reperfusion.
  • These findings support the beneficial role of MD adherence in both primary and secondary cardiovascular prevention.
  • MD adherence may improve treatment effectiveness in STEMI patients.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
279
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
540
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
177
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
165
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
194
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
800